Read Now
Articles
Real-World DermaSensor Results in Primary Care
See real-world DermaSensor results from a primary care practice, including skin cancer diagnoses, diagnostic yield, referrals, and device use.
Skin Cancer Insights
DermaSensor Resources
Discover our latest resources like blog posts, webinars, white papers, case studies and solution briefs, with insightful information on the AI-powered device that detects skin cancer.
Read Now
Read Now
Publications
AI-powered skin cancer detection at the point of care for rural health
The rural skin cancer crisis Skin cancer is the most common cancer in the U.S., yet rural patients face a compounding access crisis that delays diagnosis, drives worse outcomes, and strains limited dermatology capacity. What DermaSensor brings DermaSensor — device overview DermaSensor[TM] is the first FDA-cleared AI-powered skin cancer risk detection device designed for primary […]
Read Now
Publications
DermaSensor Product Brochure
Better decisions, better detection, more accurate management DermaSensor empowers physicians by providing objective, actionable risk results to aid in skin cancer detection by assessing cellular and sub-cellular features that cannot be seen visually or dermoscopically. Features Indications for use The DermaSensor™ device is indicated for evaluating skin lesions suggestive of melanoma, basal cell carcinoma, and/or […]
Read Now
Publications
Clinical Registry Case Study: Assessing the Impact of Integrating DermaSensor™ into Primary Care for Skin Cancer Management Marcy Goisse, MD; Betty Thomas, MD. Montgomery Medical, Inc., Smithfield and Brownsville, PA
The DermaSensor DeviceDermaSensor is a validated, FDA-cleared handheld device that non-invasively evaluates skin lesions forcancer. It captures spectral samples of a lesion and, using a proprietary algorithm, classifies the lesion’sspectral properties against those of known malignant and benign lesions. Real-World Impact: More Cancers Detected, with Greater Diagnostic EfficiencyDrs. Goisse and Thomas reviewed skin-lesion data and […]
Read Now
Publications
Summary of DermaSensor Device Safety and Effectiveness Results From Three Clinical Studies
FDA Cleared
Read Now
Publications
Validation of a Handheld Elastic Scattering Spectroscopy Device on Lesions Concerning for Melanoma
Introduction and Objectives Skin cancer is the most common cancer worldwide and its most common types are basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma [1,2]. One in five Americans will develop skin cancer by the age of 70 and more than two people die of skin cancer in the U.S. every hour […]
Read Now
Publications
Clinical Utility of an Elastic Scattering Spectroscopy Device in Assisting Primary Care Physicians’ Detection of Skin Cancers
Background and Objective Access to a dermatologist for diagnosis and management of skin cancer is challenging, as around 40% of the United States population live in areas that have limited access to a dermatologist [1]. This puts primary care physicians (PCPs) in an integral role for early detection of skin cancers, as early detection of […]
Read Now
Publications
Clinical Performance of Novel Elastic Scattering Spectroscopy (ESS) in Detection of Skin Cancer: A Blinded, Prospective, Multi-Center Clinical Trial
Stephen P Merry, MD1; Brian McCormick, MD2; Vivien Nguyen PharmD4, Kiran Chatha, MD, MPH4; Ivana Croghan, PhD1,, David Leffell, MD3 1 Mayo Clinic, Rochester, MD; 2 Hampton Family Practice, Hampton, VA; 3 Yale School of Medicine, New Haven, CT; 4 DermaSensor Inc. FDA Cleared.Available in the United States. Background and Objective Skin cancer is by far the most common type of cancer […]
Read Now
Publications
Publications 2026
